As of 2025-10-07, the Intrinsic Value of Solara Active Pharma Sciences Ltd (SOLARA.NS) is 223.35 INR. This SOLARA.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 613.30 INR, the upside of Solara Active Pharma Sciences Ltd is -63.60%.
The range of the Intrinsic Value is 152.92 - 336.33 INR
Based on its market price of 613.30 INR and our intrinsic valuation, Solara Active Pharma Sciences Ltd (SOLARA.NS) is overvalued by 63.60%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 152.92 - 336.33 | 223.35 | -63.6% |
| DCF (Growth 10y) | 290.76 - 543.35 | 388.65 | -36.6% |
| DCF (EBITDA 5y) | 653.33 - 1,007.06 | 799.47 | 30.4% |
| DCF (EBITDA 10y) | 658.99 - 1,098.71 | 839.41 | 36.9% |
| Fair Value | 25.46 - 25.46 | 25.46 | -95.85% |
| P/E | 132.61 - 173.35 | 149.27 | -75.7% |
| EV/EBITDA | 464.69 - 655.17 | 571.53 | -6.8% |
| EPV | 1.78 - 42.03 | 21.90 | -96.4% |
| DDM - Stable | 24.24 - 46.80 | 35.52 | -94.2% |
| DDM - Multi | 135.78 - 207.84 | 164.59 | -73.2% |
| Market Cap (mil) | 29,530.40 |
| Beta | 1.06 |
| Outstanding shares (mil) | 48.15 |
| Enterprise Value (mil) | 37,450.09 |
| Market risk premium | 8.31% |
| Cost of Equity | 16.25% |
| Cost of Debt | 14.52% |
| WACC | 15.30% |